Xeltis Hemodialysis Access Graft (aXess) US Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 140 participants.
Also called NCT06494631
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 140 participants
- Sponsor
- Registry
-
NCT06494631
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT06494631. Allocation not applicable; no masking; primary purpose treatment. Start 2024-11-11 (actual); primary completion 2028-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Xeltis Hemodialysis Access Graft (aXess) US Study
- Condition
- End Stage Renal Disease
- Intervention (Device)
- Xeltis Hemodialysis Access (aXess) graft
- Lead sponsor
- Xeltis
Record details
- Record id
cardio:ct-nct06494631- Content hash
f9da6d92b1566727135c001a04c5e930526a3c852f7ce9283b5364d448f37ecc